Clinical Trial Recruitment Companies

When a sponsor or site cannot generate enough eligible participants through its own referral networks, registries, and outreach staff, the work is often handed in whole or in part to a third-party vendor that specializes in patient recruitment. That vendor landscape — who these companies are, what services they actually sell, and how a sponsor or site should evaluate one — is a distinct question from recruitment strategy itself. CASRAI’s guide to clinical trial patient recruitment methods, screening, and enrollment covers the channels and compliance requirements that apply whether a site runs recruitment in-house or contracts it out. This guide covers the vendor side: the categories of company that offer recruitment as a service, what they typically provide, and the evaluation criteria a research administrator should apply before signing a contract.

What Is a Clinical Trial Recruitment Company?

A clinical trial recruitment company (also called a patient recruitment vendor, recruitment agency, or enrollment vendor) is a third-party organization that a sponsor, CRO, or individual site contracts to perform some or all of the work of identifying, reaching, pre-screening, or converting prospective participants into enrolled trial subjects. This is a services market that sits alongside, and sometimes overlaps with, the broader Contract Research Organization (CRO) industry — some full-service CROs offer recruitment as one bundled service among many (monitoring, data management, biostatistics, pharmacovigilance), while other companies specialize in recruitment and enrollment as their sole or primary offering and are contracted alongside, not instead of, a trial’s CRO.

Recruitment vendors are also distinct from a Site Management Organization (SMO), a company that provides operational support — feasibility assessment, site startup, staffing, regulatory documentation, and recruitment support — from the investigative site’s side of the relationship, as opposed to a CRO or recruitment vendor working on the sponsor’s side. A related category sometimes referenced in industry material is the Patient Access Organization (PAO), which offers patient-facing educational resources and trial-finder tools rather than working directly for a sponsor or site.

The Main Categories of Recruitment Vendor

Industry framing of this market (see the Society for Clinical Research Sites’ patient recruitment landscape resource, cited below) generally groups recruitment vendors into a small number of overlapping segments rather than one uniform vendor type:

Content and outreach agencies. The longest-established category: creative and communications agencies that develop recruitment messaging, translate and shepherd materials through IRB/ethics review, build study websites and landing pages, and plan paid media placement (digital, print, radio, social).
Outreach-plus-technology vendors. Vendors that pair digital advertising campaigns with screening tools and funnel analytics, tracking a prospective participant from first ad impression through referral to the site.
Screening and workflow technology (SaaS) platforms. Software vendors focused on pre-screening questionnaires, referral tracking and routing, and adjacent functions such as electronic consent — often sold as a platform a site or sponsor operates directly rather than a fully managed service.
Patient-identification and data-matching platforms. Vendors that use electronic health record data, insurance claims data, or other real-world datasets (increasingly combined with AI-based matching) to pre-identify potentially eligible candidates before any outreach occurs.
Multi-study search platforms. A newer category — consumer-facing platforms, increasingly built around large language models, that let a prospective participant search across many studies at once rather than being recruited into a single trial’s funnel.

Site Management Organizations and, for full-service engagements, large CROs sit alongside these categories rather than fitting neatly inside one of them — both can bundle recruitment support into a broader site-operations or trial-management contract rather than selling it as a discrete service.

Services a Recruitment Vendor Typically Provides

Exactly what is included varies by category and by contract scope, but the services most commonly offered across this vendor landscape include:

Feasibility and landscape assessment for a given protocol and target population
Messaging and creative development, including translation and IRB-ready material packages
Media planning and buying (digital, social, broadcast, print)
Study websites, landing pages, and online eligibility pre-screeners
Call center or contact center services for initial pre-screening calls
Referral management and tracking software, often with a dashboard reporting funnel metrics back to the sponsor or site
Community outreach staff or partnerships, particularly for reaching populations underrepresented in a trial’s current pool
EHR- or claims-based pre-identification of potentially eligible patients
Patient navigation or concierge support through screening and early participation
Retention support once a participant is enrolled

No single vendor typically offers the full list above at the same depth — part of vendor selection (below) is matching the specific gap in a sponsor’s or site’s own capability to the vendor category built to fill it.

How Sponsors and Sites Evaluate and Select a Recruitment Vendor

The Society for Clinical Research Sites (SCRS) frames vendor selection around a small set of practical questions rather than a single scoring formula, and the criteria below reflect that framing:

Internal capability gaps. Before selecting a vendor category, identify what the site or sponsor’s own team genuinely cannot do — media buying at scale, EHR-based pre-identification, and multilingual creative development are common gaps that justify outside vendor support, as opposed to channels a site can run effectively on its own.
Protocol and disease factors. Disease prevalence and how easily a prospective participant can self-identify as a candidate (a common, well-understood condition versus a rare disease requiring specialist identification) strongly shape which vendor category is actually effective for a given trial.
Geography and local context. A vendor’s approach needs to adapt to local language, culture, and media habits at each site, not just translate a single national campaign.
Vendor fit, scalability, and cost model. How a vendor’s workflow, technology, and pricing structure line up with the sponsor’s or site’s own systems and budget, and whether the vendor can scale from a single-site pilot to a multi-site, multi-country program if the trial expands.
Therapeutic-area experience and track record. Prior performance recruiting for comparable indications and populations, including realistic accrual-rate evidence rather than aspirational projections.
Technology integration. Whether the vendor’s referral-tracking or screening platform can feed data into the site’s or sponsor’s existing Clinical Trial Management System (CTMS) rather than operating as a disconnected system requiring manual reconciliation.
Compliance track record. Whether the vendor has direct experience getting recruitment materials through IRB review without repeated rework, and whether its standard contract and data-handling practices already anticipate the requirements below.

Procurement for a recruitment vendor typically runs through the same request-for-proposal (RFP) and bid-comparison process used for other clinical trial vendors, evaluated against the criteria above rather than price alone — a lower-cost vendor with poor therapeutic-area fit or a weak compliance track record routinely costs more in delayed enrollment and rework than a more expensive vendor selected on fit.

Compliance and Contracting Considerations

Using a third-party vendor does not change or reduce the underlying regulatory requirements that apply to recruitment — it changes who performs the work, not what is required of the work:

IRB/REC review still applies. Any direct advertising material a vendor produces — ad copy, images, video, study websites — still requires IRB or REC review and approval before use, the same as material a site or sponsor produces in-house. See CASRAI’s patient recruitment guide for the FDA/OHRP basis of this requirement and the narrow basic-listing exemption.
The sponsor retains oversight and ultimate responsibility. The same principle that governs delegating trial conduct to a CRO under ICH E6(R2) Section 5.2 and, in the US, 21 CFR 312.52 — that any transferred duty must be specified in writing and the sponsor remains responsible for overall trial quality and integrity — applies in substance to recruitment vendor relationships as well: contracting out recruitment does not transfer accountability for how participants were identified, approached, or consented.
Data privacy and access agreements. A vendor that accesses protected health information or electronic health record data for pre-identification purposes in the US typically requires a HIPAA Business Associate Agreement (BAA) in addition to the underlying services contract, and comparable data-protection agreements apply under other jurisdictions’ frameworks (for example GDPR in the EU) when a vendor processes personal data on the sponsor’s or site’s behalf. Data-handling terms — what the vendor may retain, for how long, and under what deletion obligations — are a standard part of recruitment-vendor contracting, not an optional add-on.
Fee structures vary and should be understood before signing. Recruitment vendor contracts are commonly structured around cost-per-lead, cost-per-screened-candidate, cost-per-randomized-participant, a fixed program fee, or an embedded-staff model resembling a Functional Service Provider (FSP) arrangement. Which structure best aligns vendor incentives with actual enrollment (rather than lead volume alone) is a real point of negotiation worth working through explicitly rather than defaulting to whatever a vendor proposes first.

Frequently Asked Questions

What is the difference between a CRO and a patient recruitment company?

A Contract Research Organization typically manages some or all of a trial’s overall conduct on the sponsor’s behalf — monitoring, data management, regulatory submissions, and often recruitment as one bundled service among many. A patient recruitment company is usually narrower in scope, specializing in identifying, reaching, and pre-screening prospective participants, and may be contracted separately from, and alongside, a trial’s CRO.

What is a Site Management Organization (SMO)?

A Site Management Organization provides operational support to investigative sites — feasibility assessment, startup, staffing, regulatory documentation, and recruitment support — working from the site’s side of the relationship, as distinct from a CRO or recruitment vendor, which typically works on the sponsor’s side.

Does using a recruitment vendor change IRB approval requirements for advertising?

No. Any direct advertising material intended for prospective participants still requires IRB or REC review and approval before use regardless of whether a site, a sponsor, or a contracted vendor produced it, with the same narrow basic-listing exemption that applies to in-house material.

How are clinical trial recruitment vendors typically paid?

Common fee structures include cost-per-lead, cost-per-screened-candidate, cost-per-randomized-participant, a fixed program fee, and embedded-staff arrangements similar to a Functional Service Provider model. The specific structure shapes what the vendor is actually incentivized to deliver, which is worth evaluating alongside price.

Does contracting out recruitment reduce the sponsor’s regulatory responsibility?

No. Consistent with the general principle governing delegation to a CRO under ICH E6(R2) and, in the US, 21 CFR 312.52, transferring recruitment work to a vendor does not transfer accountability for how participants were identified, approached, or consented — the sponsor retains overall responsibility for trial conduct and data integrity.